2026-14692NoticeWallet

California Lab Seeks Tariff Break for Making Ozempic Ingredients

Published Date: 7/21/2026

Notice

Summary

PolyPeptide Laboratories in Torrance, California wants to make special peptides and medicines inside Foreign-Trade Zone 202, which means they can save money by paying less or no import taxes on some ingredients. This change helps them produce drugs like liraglutide and linaclotide more cheaply and efficiently. The government got their request on July 13, 2026, and if approved, it could speed up production and cut costs.

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Peptide Manufacture Gets FTZ Duty Relief

PolyPeptide Laboratories asked to make peptides inside Foreign-Trade Zone (FTZ) 202 in Torrance, California so certain finished products (liraglutide, nectin, linaclotide, and other peptides) would be admitted duty-free. The request lists many imported ingredient items with duty rates ranging from duty-free up to 6.5% and was received July 13, 2026; public comments close August 31, 2026.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
7/21/2026

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Foreign-Trade Zones Board
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register